Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Essler

Showing results (141-150 of 309) with videos related to

Pageof 31
Sort By:
Plos One|June 1, 2013
Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenationChristian Wulbrand, Christof Seidl, Florian C Gaertner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Local motion correction for lung tumours in PET/CT--first resultsRalph A Bundschuh, Axel Martínez-Möller, Markus Essler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2017
The impact of repeated cycles of radioligand therapy using [<sup>177</sup>Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancerAnna Yordanova, Anja Becker, Elisabeth Eppard, et al.
HNO|April 29, 2017
[PET-CT in head and neck cancer]T Send, B Kreppel, F C Gaertner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2017
Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30Milka Marinova, Martin Mücke, Lukas Mahlberg, et al.
Investigational New Drugs|June 6, 2020
Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-CTLA-4 therapy by bioinformaticsYing Zhang, Francesca Garofano, Xiaolong Wu, et al.
Diagnostics (Basel, Switzerland)|December 17, 2024
A Tumor Volume Segmentation Algorithm Based on Radiomics Features in FDG-PET in Lung Cancer Patients, Validated Using Surgical SpecimensLena Bundschuh, Jens Buermann, Marieta Toma, et al.
Annals of Translational Medicine|July 16, 2021
Decision-support for treatment with <sup>177</sup>Lu-PSMA: machine learning predicts response with high accuracy based on PSMA-PET/CT and clinical parametersSobhan Moazemi, Annette Erle, Zain Khurshid, et al.
Frontiers in Genetics|August 21, 2023
Computational analysis of heat shock proteins and ferroptosis-associated lncRNAs to predict prognosis in acute myeloid leukemia patientsFangfang Ge, Yulu Wang, Amit Sharma, et al.
Frontiers in Immunology|October 25, 2021
NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited CoactivationXiaolong Wu, Amit Sharma, Johannes Oldenburg, et al.
Pageof 31

Showing results (141-150 of 309) with videos related to

Sort By:
Pageof 31
Plos One|June 1, 2013
Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenationChristian Wulbrand, Christof Seidl, Florian C Gaertner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Local motion correction for lung tumours in PET/CT--first resultsRalph A Bundschuh, Axel Martínez-Möller, Markus Essler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2017
The impact of repeated cycles of radioligand therapy using [<sup>177</sup>Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancerAnna Yordanova, Anja Becker, Elisabeth Eppard, et al.
HNO|April 29, 2017
[PET-CT in head and neck cancer]T Send, B Kreppel, F C Gaertner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2017
Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30Milka Marinova, Martin Mücke, Lukas Mahlberg, et al.
Investigational New Drugs|June 6, 2020
Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-CTLA-4 therapy by bioinformaticsYing Zhang, Francesca Garofano, Xiaolong Wu, et al.
Diagnostics (Basel, Switzerland)|December 17, 2024
A Tumor Volume Segmentation Algorithm Based on Radiomics Features in FDG-PET in Lung Cancer Patients, Validated Using Surgical SpecimensLena Bundschuh, Jens Buermann, Marieta Toma, et al.
Annals of Translational Medicine|July 16, 2021
Decision-support for treatment with <sup>177</sup>Lu-PSMA: machine learning predicts response with high accuracy based on PSMA-PET/CT and clinical parametersSobhan Moazemi, Annette Erle, Zain Khurshid, et al.
Frontiers in Genetics|August 21, 2023
Computational analysis of heat shock proteins and ferroptosis-associated lncRNAs to predict prognosis in acute myeloid leukemia patientsFangfang Ge, Yulu Wang, Amit Sharma, et al.
Frontiers in Immunology|October 25, 2021
NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited CoactivationXiaolong Wu, Amit Sharma, Johannes Oldenburg, et al.
Pageof 31